In partnership with

This Startup Is Making Plastic Obsolete

Timeplast created a plastic that dissolves in water, leaving no waste. Their tech could revolutionize the $1.3T plastic industry. That’s why 7,000+ people have already invested, and you have only a few days left to join them. Invest in Timeplast by July 31 at midnight.

This is a paid advertisement for Timeplast’s Regulation CF Offering. Please read the offering circular at invest.timeplast.com.

THE MONEY IDEA💡
2 Companies To Buy, 2 To Sell

Welcome, we are {{active_subscriber_count}} Money Masters and counting!

Earnings season has offered fresh insights into which companies still have room to run and which may be priced for perfection. With analysis from Morningstar experts, Verizon and Northrop Grumman stand out as undervalued names with strong long-term potential. Meanwhile, Intuitive Surgical and Dover look overextended after recent gains and could face pressure ahead.

THE MONEY IDEA💡
2 Companies To Buy

Industry: Communications / Telecom Services
Current Status: Undervalued; 4-star rating, narrow moat, medium uncertainty

Bottom Line: Verizon combines a reliable dividend, attractive valuation, and operational stability in a defensive sector.

Industry: Aerospace & Defense
Current Status: Undervalued; 4-star rating, wide moat, medium uncertainty

Bottom Line: Northrop offers defense exposure, earnings momentum, and a valuation that hasn’t caught up to the fundamentals.

THE MONEY IDEA💡
2 Companies To Sell

Industry: Industrials / Diversified Machinery
Current Status: Overvalued; 2-star rating, high uncertainty

  • Over Fair Value – Shares remain around 11% above Morningstar’s estimate despite lackluster momentum.

  • Weak Income Yield – A 1.1% dividend is low for an industrial name and doesn’t offer strong support.

  • Flat Performance – Q2 results were solid but uninspiring, failing to change the growth narrative.

  • Conglomerate Complexity – Diverse business units dilute focus and make the stock harder to value.

  • More Attractive Alternatives – Investors seeking yield or industrial growth may find better options elsewhere.

Bottom Line: Dover lacks near-term catalysts or income appeal and trades above its long-term fair value estimate.

Industry: Healthcare / Medical Devices
Current Status: Overvalued; 2-star rating, medium uncertainty

  • Premium Valuation – Shares trade nearly 40% above fair value, reflecting lofty expectations.

  • Earnings Already Priced In – Even strong growth is unlikely to drive further upside from current levels.

  • Vulnerable Multiple – A forward P/E above 60 means even small earnings misses could cause big pullbacks.

  • No Dividend Appeal – With no dividend, the stock offers little cushion for risk-averse investors.

  • Execution Risk – Any delays in system upgrades or procedural volume softness could hit sentiment hard.

Bottom Line: Intuitive is a strong company but its current valuation leaves minimal margin for error.

Need our expert tips? Grab our Money Mastery guides today.

QUOTE CORNER📄
Quote of The Week

You are now closer to money mastery!🎉
What did you think of this week’s newsletter?
Hit reply and share some feedback!
Start your own newsletter with Beehiiv
and use SparkLoop to grow it faster today!

How was this newsletter (honestly)?

Login or Subscribe to participate

Modernize Out Of Home with AdQuick

AdQuick unlocks the benefits of Out Of Home (OOH) advertising in a way no one else has. Approaching the problem with eyes to performance, created for marketers and creatives with the engineering excellence you’ve come to expect for the internet.

You can learn more at www.AdQuick.com

The Content is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.

Reply

or to participate

More From Capital

No posts found